Navigation Links
First Live U.S. Demonstration of Cellvizio GI In Vivo Cellular Imaging Technology to Occur at Johns Hopkins Conference
Date:3/5/2008

PHILADELPHIA, March 5 /PRNewswire/ -- Cellvizio Inc., a leader in in vivo cellular imaging, announced today that the first live U.S. demonstration of its Cellvizio(R) GI technology will be conducted March 10, 2008, during the Johns Hopkins University School of Medicine's Eighth Annual Gastroenterology and Hepatology Viva La Vida Conference.

Cellvizio Inc. is the U.S. subsidiary of Paris-based Mauna Kea Technologies and develops and markets Cellvizio, a fundamentally new endoscopic imaging approach which could improve patient care by eliminating the need for unnecessary biopsies and could enhance the diagnosis of a broad range of diseases via in vivo cellular imaging.

The Cellvizio GI procedure will be performed at the Johns Hopkins Hospital in Baltimore during an endoscopy to assist with the diagnosis of Barrett's esophagus. It will be seen live via satellite by attendees of the conference, which is being held March 10-15 in San Juan, Puerto Rico. Gastroenterologists, surgeons and other healthcare professionals with an interest in gastroenterology and hepatology are participating in the program.

"Cellvizio allows physicians to view live tissue inside the body at the cellular level in real-time with a miniaturized microscope threaded through an endoscope and has the potential to benefit patients by reducing invasiveness while speeding up diagnosis," explained Sacha Loiseau, president, CEO and founder of Mauna Kea Technologies. "For example, a current diagnosis of Barrett's esophagus may require 10 to 50 biopsies to be taken and analyzed by a pathologist off line. The use of Cellvizio during this procedure could help reduce this number significantly by allowing physicians to avoid unnecessary biopsies."

Cellvizio GI is commercially available in Europe and in the United States.

About Mauna Kea Technologies:

Mauna Kea Technologies leads the growing in vivo cellular imaging market enabling physicians to visualize, diagnose and treat pathologies that can not be seen using other imaging techniques. Mauna Kea Technologies' flagship Cellvizio system provides microscopic visualization of mucosal tissue and promises to improve clinical outcomes by increasing the diagnostic yield of existing endoscopic procedures. With over 1000 Cellvizio procedures completed to date, Mauna Kea Technologies is currently focused on the gastroenterology and pulmonology markets. The company plans to expand into other markets in the future. The company also has a distribution agreement with Leica Microsystems to sell products for the Small Animal Imaging market in Europe, the U.S. and Japan. For more information about Mauna Kea Technologies: http://www.maunakeatech.com

About The Conference:

The Eighth Annual Gastroenterology and Hepatology: Viva la Vida conference will provide, through formal lectures, followed by questions and answers, a discussion of various disorders, with an emphasis on recent developments. Participants will be updated on the latest management of GI cancers and approaches for the difficult GI bleeder. Endoscopic imaging and therapies will be demonstrated live from the Johns Hopkins Hospital and University of Puerto Rico by renowned international experts.
For more information:

http://www.hopkinscme.net/CourseDetail.aspx?course_code=80016767

Contact:

Erich Sandoval

Lazar Partners

Tel. 212-867-1773

E-mail: esandoval@lazarpartners.com


'/>"/>
SOURCE Cellvizio Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Nova Biosource Fuels Announces First Funding Under $41 Million Senior Secured Credit Facility
2. Enerkem announces progress on construction of Canadas first cellulosic ethanol plant
3. Actavis Receives Approval for Irinotecan Hydrochloride Injection; Extends US Portfolio with First Injectable Product
4. Center for Molecular Medicine Among First to Offer New FDA-Approved Test to Aid in Treatment of Prostate Cancer
5. BSPs New Line of HyperQ Products: Bedside Ischemia Monitoring Systems Announces Successful Results of First Feasibility Study
6. First Complete Career Service for Life-Science Professionals
7. Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
8. Biopure Announces 2008 First Quarter Financial Results
9. Addrenex Pharmaceuticals Reaches Milestone with Filing of NDA for First Product, CloniBID, to Treat Hypertension
10. European Company NovaSecta Joins First Chinese CRO Service Alliance for Drug Discovery Solutions
11. Carrington Subsidiary DelSite Starts Making Test Batches of First Bird Flu Vaccine Offering Needle-free Self-Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... -- VMS BioMarketing, a leading provider of patient support solutions, has ... (CNE) network, which will launch this week. The VMS CNEs ... professionals to enhance the patient care experience by delivering peer-to-peer ... care professionals to help women who have been diagnosed and ... ...
(Date:10/11/2017)... ... October 11, 2017 , ... Disappearing forests and increased ... of over 5.5 million people each year. Especially those living in larger cities are ... - based in one of the most pollution-affected countries globally - decided to take ...
(Date:10/11/2017)... Florida (PRWEB) , ... October 11, 2017 , ... ... Drug Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 ... for the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... conjugate (ADC) therapeutics, today confirmed licensing rights that give it exclusive global ... technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). Additionally, ...
Breaking Biology Technology:
(Date:5/16/2017)... DALLAS , May 16, 2017   ... for health organizations, and MD EMR Systems ... certified development partner for GE, have established a ... Patient Portal product and the GE Centricity™ products, ... Centricity EMR. These new integrations ...
(Date:4/17/2017)... Florida , April 17, 2017 NXT-ID, ... technology company, announces the filing of its 2016 Annual Report on ... and Exchange Commission. ... on Form 10-K is available in the Investor Relations section of ... as on the SEC,s website at http://www.sec.gov . ...
(Date:4/11/2017)... No two people are believed to ... York University Tandon School of Engineering and Michigan ... partial similarities between prints are common enough that ... and other electronic devices can be more vulnerable ... in the fact that fingerprint-based authentication systems feature ...
Breaking Biology News(10 mins):